Bindu Manne

Bindu currently serves as the Head of Market Development and Commercialization at Ocuphire Pharma, bringing over 17 years of experience and an extensive network in ophthalmics across all sub-specialties, including cornea, retina, and glaucoma. She’s been involved in ophthalmic product launches in both commercial and medical functions, including sales, thought-leader development, market development, professional education, public relations, and medical affairs at large and small pharmaceutical and medical device companies.

Most recently, Bindu served as the Director, Professional Affairs at Equinox Ophthalmic, Inc. to drive the medical and commercial strategy for the potential approval of a first-in-class non-invasive wearable device, Multi-Pressure Dial, to treat severe and normal-tension glaucoma, in the US and Asia, through a durable medical equipment model. Prior, she led Market Development at Ocular Therapeutix to launch the first intracanalicular drug delivery platform, Dextenza ® (dexamethasone ophthalmic insert) 0.4 mg for patients undergoing ophthalmic surgery with pass-through reimbursement. She accelerated the launch success by simultaneously building the foundational adoption from the Key Opinion Leaders, practice administrators, and ophthalmic surgery centers. Bindu played a vital role in Market Development at Shire to grow the regional and national thought-leadership for Xiidra® (lifitegrast ophthalmic solution) 5%.